Steven A. Lisi has bought XAIR on 10 days since Jun 2019

Steven A. Lisi is Chairman and Chief Executive Officer of Beyond Air, Inc. (NASDAQ: XAIR), a commercial-stage medical device and biopharmaceutical company focused on nitric oxide therapies for respiratory illnesses, neurological disorders, and solid tumors.( Aged 54, he has served as CEO since June 14, 2017, and as a director since January 13, 2017, while also directing the company's wholly-owned subsidiary, Beyond Air Ltd., since June 2016.( Lisi owns approximately 3.3 million shares of XAIR stock.(

Prior to Beyond Air, Lisi was Senior Vice President of Business and Corporate Development at Avadel Technologies (AVDL), where he led restructuring efforts, raised over $121-125 million in equity, sold assets, rationalized the pipeline, and grew enterprise value from ~$100 million to ~$1 billion in three years.( He spent 18 years as a healthcare investor and portfolio manager at firms including OrbiMed, SAC Capital, Millennium Partners, Panacea Asset Management, and Deerfield Management.( Lisi holds a Master’s degree in International Business from Pepperdine University and currently serves as a director at Mico Innovations and Chairman of Beyond Cancer.(

Written by Perplexity from public sources.